[go: up one dir, main page]

AR038305A1 - Composicion farmaceutica dispersable oralmente de perindopril - Google Patents

Composicion farmaceutica dispersable oralmente de perindopril

Info

Publication number
AR038305A1
AR038305A1 ARP030100195A ARP030100195A AR038305A1 AR 038305 A1 AR038305 A1 AR 038305A1 AR P030100195 A ARP030100195 A AR P030100195A AR P030100195 A ARP030100195 A AR P030100195A AR 038305 A1 AR038305 A1 AR 038305A1
Authority
AR
Argentina
Prior art keywords
perindopril
pharmaceutical composition
organally
dispersable
harvested
Prior art date
Application number
ARP030100195A
Other languages
English (en)
Inventor
Herve Rolland
Marc Julien
Patrick Wuthrich
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR038305A1 publication Critical patent/AR038305A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición farmacéutica sólida dispersable oralmente de perindopril que contiene perindopril o una de sus sales farmacéuticamente aceptables, y gránulos que consisten en lactosa y almidón cosecados.
ARP030100195A 2002-01-23 2003-01-23 Composicion farmaceutica dispersable oralmente de perindopril AR038305A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200790A FR2834893B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de perindopril

Publications (1)

Publication Number Publication Date
AR038305A1 true AR038305A1 (es) 2005-01-12

Family

ID=27589554

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100195A AR038305A1 (es) 2002-01-23 2003-01-23 Composicion farmaceutica dispersable oralmente de perindopril

Country Status (26)

Country Link
US (3) US20050106237A1 (es)
EP (1) EP1467750B1 (es)
JP (1) JP4090997B2 (es)
KR (1) KR100588224B1 (es)
CN (1) CN1658898B (es)
AR (1) AR038305A1 (es)
AT (1) ATE332690T1 (es)
AU (1) AU2003215708B2 (es)
BR (1) BRPI0307048B1 (es)
CA (1) CA2473205C (es)
CY (1) CY1105655T1 (es)
DE (1) DE60306747T2 (es)
DK (1) DK1467750T3 (es)
EA (1) EA007181B1 (es)
ES (1) ES2268372T3 (es)
FR (1) FR2834893B1 (es)
GE (1) GEP20063821B (es)
MA (1) MA27099A1 (es)
MX (1) MXPA04007195A (es)
NO (1) NO333723B1 (es)
NZ (1) NZ533821A (es)
PL (1) PL205473B1 (es)
PT (1) PT1467750E (es)
UA (1) UA78279C2 (es)
WO (1) WO2003061691A1 (es)
ZA (1) ZA200405009B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067887A2 (en) * 2004-03-24 2005-07-28 Actavis Group Formulations of ramipril
DE102004019845A1 (de) * 2004-03-29 2005-10-20 Krka Tovarna Zdravil D D Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
SK50252005A3 (sk) * 2005-03-22 2006-10-05 Vúlm, A.S. Farmaceutický prípravok obsahujúci perindopril erbumín, spôsob jeho prípravy a stabilizácie
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
SI2886108T2 (sl) * 2013-12-23 2023-02-28 Dr. Falk Pharma Gmbh Optimizirana farmacevtska formulacija za zdravljenje vnetnih sprememb požiralnika
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
ATE253899T1 (de) * 1994-01-31 2003-11-15 Yamanouchi Pharma Co Ltd Intraoral löslicher formpressling und verfahren zu seiner herstellung
JP2002505269A (ja) * 1998-03-06 2002-02-19 エウランド インターナショナル ソシエタ ペル アチオニ 急速崩壊錠剤
US6740339B1 (en) * 1999-06-18 2004-05-25 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
DE60036205T2 (de) * 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose
US6651768B2 (en) * 2000-11-06 2003-11-25 Bombardier Inc. Snowmobile engine mount
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
CA2473205C (fr) 2010-05-18
KR100588224B1 (ko) 2006-06-12
JP2005523256A (ja) 2005-08-04
FR2834893A1 (fr) 2003-07-25
GEP20063821B (en) 2006-05-10
WO2003061691A1 (fr) 2003-07-31
UA78279C2 (en) 2007-03-15
MXPA04007195A (es) 2004-10-29
HK1076743A1 (en) 2006-01-27
EP1467750B1 (fr) 2006-07-12
US20050106237A1 (en) 2005-05-19
BRPI0307048B1 (pt) 2015-06-30
FR2834893B1 (fr) 2004-02-27
AU2003215708B9 (en) 2003-09-02
NZ533821A (en) 2005-08-26
DK1467750T3 (da) 2006-11-13
EA007181B1 (ru) 2006-08-25
BR0307048A (pt) 2004-10-26
US20100267799A1 (en) 2010-10-21
EA200400884A1 (ru) 2004-12-30
CY1105655T1 (el) 2010-12-22
ATE332690T1 (de) 2006-08-15
EP1467750A1 (fr) 2004-10-20
AU2003215708B2 (en) 2007-07-19
ES2268372T3 (es) 2007-03-16
CN1658898B (zh) 2012-10-03
US20120076856A1 (en) 2012-03-29
MA27099A1 (fr) 2004-12-20
PT1467750E (pt) 2006-11-30
DE60306747D1 (de) 2006-08-24
CN1658898A (zh) 2005-08-24
PL205473B1 (pl) 2010-04-30
ZA200405009B (en) 2005-08-31
AU2003215708B8 (en) 2003-09-02
CA2473205A1 (fr) 2003-07-31
NO20043473L (no) 2004-08-20
DE60306747T2 (de) 2007-08-02
NO333723B1 (no) 2013-09-02
JP4090997B2 (ja) 2008-05-28
PL370162A1 (en) 2005-05-16
KR20040078130A (ko) 2004-09-08

Similar Documents

Publication Publication Date Title
AR038207A1 (es) Composicion farmaceutica dispersable oralmente de agomelatina
LTC1575566I2 (es)
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
EP1587474A3 (en) Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
NO20045065L (no) Nytt formatsalt av o-desmetyl-venlafaxin
WO2003048081A3 (en) Glycinamides as factor xa inhibitors
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
NO20052469D0 (no) Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2.
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
NO20024891L (no) Farmasöytiske sammensetninger
WO2003047520A3 (en) SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
AR038206A1 (es) Composicion farmaceutica dispersable oralmente de ivabradina
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
WO2003015779A3 (de) Matrixkontrolliertes transdermales therapeutisches system zur anwendung von pramipexol und ropinirol
SE0101932D0 (sv) Pharmaceutical combinations
WO2005007137A3 (de) Ambroxolhaltige tabletten
AU2003224747A1 (en) Technetium-labeled rotenone derivatives, and methods of use thereof
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
AU2003258630A1 (en) Pyrimidine derivatives as selective cox-2 inhibitors
AR038208A1 (es) Composicion farmaceutica dispersable oralmente de mitiglinida

Legal Events

Date Code Title Description
FC Refusal